Related references
Note: Only part of the references are listed.MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview
Carmelo Tibaldi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis
Yang Zhou et al.
BIOMARKERS IN MEDICINE (2015)
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
Norashikin Zakaria et al.
BMC CANCER (2015)
Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling
Weiling He et al.
BMC CANCER (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway
Daisuke Douchi et al.
CANCER LETTERS (2015)
The emerging role of microRNAs in resistance to lung cancer treatments
Lauren MacDonagh et al.
CANCER TREATMENT REVIEWS (2015)
Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators
Jung Min Song et al.
CARCINOGENESIS (2015)
MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2
An Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
microRNA regulation of Wnt signaling pathways in development and disease
Jia L. Song et al.
CELLULAR SIGNALLING (2015)
Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells
Jin-Hong Xu et al.
CHINESE MEDICAL JOURNAL (2015)
Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer
Lele Song et al.
CLINICAL COLORECTAL CANCER (2015)
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
Guus M. Bol et al.
EMBO MOLECULAR MEDICINE (2015)
Interplay between microRNAs and WNT/beta-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer
Nastaran Mohammadi Ghahhari et al.
EUROPEAN JOURNAL OF CANCER (2015)
Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment
Farhadul Islam et al.
EXPERIMENTAL CELL RESEARCH (2015)
Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy
Mahdi Shabani et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells
Emanuele-Salvatore Scarpa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin
Jhanelle E. Gray et al.
INVESTIGATIONAL NEW DRUGS (2015)
Clinical Significance of Aberrant Wnt7a Promoter Methylation in Human Non-Small Cell Lung Cancer in Koreans
Tae-Hyung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma
Jun Wang et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
Inhibition of beta-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non-small-cell Lung Cancer with a T790M Mutation
Yosuke Togashi et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Molecularly Targeted Therapies in Non-Small-Cell Lung Cancer Annual Update 2014
Daniel Morgensztern et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Stimulation of Wnt/β-catenin signaling pathway with Wnt agonist reduces organ injury after hemorrhagic shock
Michael Kuncewitch et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)
Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells
Xueyan Zhang et al.
MEDICAL ONCOLOGY (2015)
Targeting Wnts at the Source-New Mechanisms, New Biomarkers, New Drugs
Babita Madan et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Phuong N. Le et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Ror2 as a Therapeutic Target in Cancer
Zufan Debebe et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Mechanism of miR-21 via Wnt/β-catenin signaling pathway in human A549 lung cancer cells and Lewis lung carcinoma in mice
Dan Wu et al.
Asian Pacific Journal of Tropical Medicine (2015)
Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs
Asuka Nakata et al.
SCIENTIFIC REPORTS (2015)
被撤回的出版物: Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice (Retracted article. See vol. 13, 2022)
Shi-xia Cai et al.
STEM CELL RESEARCH & THERAPY (2015)
The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer
Yeonghoon Son et al.
BMC PULMONARY MEDICINE (2015)
A novel GSK3-regulated APC: Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient βcatenin destruction
Mira I. Pronobis et al.
ELIFE (2015)
Stimulation of Wnt/β-catenin signaling pathway with Wnt agonist reduces organ injury after hemorrhagic shock
Michael Kuncewitch et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)
Klotho: a novel biomarker for cancer
Xiangxiang Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling
C. Henry et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells
Wenchao Xu et al.
MOLECULAR CARCINOGENESIS (2015)
Dishevelled-3 activates p65 to upregulate p120-catenin transcription via a p38-dependent pathway in non-small cell lung cancer
Huanyu Zhao et al.
MOLECULAR CARCINOGENESIS (2015)
Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Gregory M. Botting et al.
PLOS ONE (2015)
miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells
Mariko Mine et al.
PLOS ONE (2015)
Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond
Christopher Delaney et al.
CHINESE JOURNAL OF CANCER (2015)
Flow Cytometric Analysis of CD133-and EpCAM-Positive Cells in the Peripheral Blood of Patients with Lung Cancer
Tomasz Skirecki et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling
Yi Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Cancer stem cells: A contentious hypothesis now moving forward
Michael L. O'Connor et al.
CANCER LETTERS (2014)
miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM
Qiancheng Song et al.
CANCER RESEARCH (2014)
β-Catenin Contributes to Lung Tumor Development Induced by EGFR Mutations
Sohei Nakayama et al.
CANCER RESEARCH (2014)
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Heinz-Josef Lenz et al.
CANCER SCIENCE (2014)
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins
J. Remon et al.
CANCER TREATMENT REVIEWS (2014)
Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion
Xiaojun Chen et al.
CARCINOGENESIS (2014)
Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients
Angela Coscio et al.
CARCINOGENESIS (2014)
Exploiting APC Function as a Novel Cancer Therapy
Alyssa C. Lesko et al.
CURRENT DRUG TARGETS (2014)
Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition
Xiuli Bi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway
Yimin Lu et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2014)
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
David J. Stewart
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Utilization of Liquid Chromatography Mass Spectrometry Analyses to Identify LKB1-APC Interaction in Modulating Wnt/β-Catenin Pathway of Lung Cancer Cells
Shu-Fang Jian et al.
MOLECULAR CANCER RESEARCH (2014)
MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells
Chai San Ho et al.
LUNG CANCER (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
Molecular docking studies of flavonoids for their inhibition pattern against -catenin and pharmacophore model generation from experimentally known flavonoids to fabricate more potent inhibitors for Wnt signaling pathway
Hira Iftikhar et al.
PHARMACOGNOSY MAGAZINE (2014)
β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells
Xia Fang et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Activated Leukocyte Cell Adhesion Molecule (CD166): An Inert Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
Michael Tachezy et al.
STEM CELLS (2014)
ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway
Chengyao Xie et al.
TUMOR BIOLOGY (2014)
Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status
Zhiguang Xiao et al.
ONCOTARGET (2014)
The role of nnicroRNAs in the regulation of cancer stem cells
Ryou-u Takahashi et al.
FRONTIERS IN GENETICS (2014)
Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
Masaru Katoh
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Wnt Pathway Activation Predicts Increased Risk of Tumor Recurrence in Patients With Stage I Nonsmall Cell Lung Cancer
Mark Shapiro et al.
ANNALS OF SURGERY (2013)
2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549/Wnt2 cells
Sang Bum Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer
Min Tan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer
Dawn T. Bravo et al.
BMC CANCER (2013)
Evidence for tankyrases as antineoplastic targets in lung cancer
Alexander M. Busch et al.
BMC CANCER (2013)
Distinct Radiosensitivity of Lung Carcinoma Stem-Like Side Population and Main Population Cells
Pu Xia et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells
Yuan Gao et al.
CANCER LETTERS (2013)
β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma
Chuan Xu et al.
CANCER RESEARCH (2013)
A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth
Ted Lau et al.
CANCER RESEARCH (2013)
Stem cell-like ALDHbright cellular states in EGFR-mutant non-small cell lung cancer A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin
Bruna Corominas-Faja et al.
CELL CYCLE (2013)
Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness
Kaijie Wu et al.
CELLULAR SIGNALLING (2013)
Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy
Jun Zhao et al.
CLINICAL CANCER RESEARCH (2013)
Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis
Sichuan Xi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation
Su Man Lee et al.
MOLECULES AND CELLS (2013)
Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
Martin P. Barr et al.
PLOS ONE (2013)
Down-Regulation of Canonical and Up-Regulation of Non-Canonical Wnt Signalling in the Carcinogenic Process of Squamous Cell Lung Carcinoma
Domokos Bartis et al.
PLOS ONE (2013)
Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1
Kholoud Arafat et al.
PLOS ONE (2013)
The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
Yong Yang et al.
PLOS ONE (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer stem cells in lung cancer: Evidence and controversies
Muhammad Alamgeer et al.
RESPIROLOGY (2013)
hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression
Sreedevi Avasarala et al.
BIOLOGY OPEN (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Frizzled-8 as a putative therapeutic target in human lung cancer
Hua-qing Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer
W. Gao et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner
Bo Chen et al.
CANCER BIOLOGY & THERAPY (2012)
A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
Jo Waaler et al.
CANCER RESEARCH (2012)
Tankyrase and the Canonical Wnt Pathway Protect Lung Cancer Cells from EGFR Inhibition
Matias Casas-Selves et al.
CANCER RESEARCH (2012)
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells
Wenyan Lu et al.
CELLULAR SIGNALLING (2012)
Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
Jin Sung Jang et al.
CLINICAL CANCER RESEARCH (2012)
DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer
Jian Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Wnt3 gene expression promotes tumor progression in non-small cell lung cancer
Nariyasu Nakashima et al.
LUNG CANCER (2012)
Comprehensive care and care at the center of the new recommendation HAS
Elisa Derrien
ACTUALITES PHARMACEUTIQUES (2012)
β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway
A-D Zhou et al.
ONCOGENE (2012)
Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance
Koji Okudela et al.
PATHOLOGY INTERNATIONAL (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Interactions between cancer stem cells and their niche govern metastatic colonization
Ilaria Malanchi et al.
NATURE (2012)
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
L. V. Sequist et al.
ANNALS OF ONCOLOGY (2011)
The Hypomethylation Agent Bisdemethoxycurcumin Acts on the WIF-1 Promoter, Inhibits the Canonical Wnt Pathway and Induces Apoptosis in Human Non-Small-Cell Lung Cancer
Y. -L. Liu et al.
CURRENT CANCER DRUG TARGETS (2011)
The Gamma Catenin/CBP Complex Maintains Survivin Transcription in β-catenin Deficient/Depleted Cancer Cells
Y. -M. Kim et al.
CURRENT CANCER DRUG TARGETS (2011)
Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After Surgery
Xianhua Xu et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
H Yao et al.
Blood Cancer Journal (2011)
NGX6 inhibits cell invasion and adhesion through suppression of Wnt/β-catenin signal pathway in colon cancer
Qin Guo et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Makoto Suzuki et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells
Ying Teng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
C. D. Salcido et al.
BRITISH JOURNAL OF CANCER (2010)
Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
James P. Sullivan et al.
CANCER RESEARCH (2010)
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Fumi Takahashi-Yanaga et al.
CLINICAL CANCER RESEARCH (2010)
Porcupine expression is associated with the expression of S100P and other cancer-related molecules in non-small cell lung carcinoma
Babett Bartling et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
EMX2 is epigenetically silenced and suppresses growth in human lung cancer
J. Okamoto et al.
ONCOGENE (2010)
Prostacyclin Inhibits Non-Small Cell Lung Cancer Growth by a Frizzled 9-Dependent Pathway That Is Blocked by Secreted Frizzled-Related Protein 1
Meredith Tennis et al.
NEOPLASIA (2010)
Wnt signalling and cancer stem cells
Jesus Espada et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma
G. Akiri et al.
ONCOGENE (2009)
ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/β-catenin signaling pathway
Xuomei Li et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2008)
Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2
Changgong Li et al.
BMC MOLECULAR BIOLOGY (2008)
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10
Chikako Fukukawa et al.
CANCER SCIENCE (2008)
Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung
Julien D. F. Licchesi et al.
CARCINOGENESIS (2008)
Lung cancer stem cells
Sharon R. Pine et al.
DISEASE MARKERS (2008)
A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities
Shlomo Handeli et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer
Wen Yue et al.
CARCINOGENESIS (2008)
Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung
Moying Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor γ
Robert A. Winn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Silencing of bidirectional promoters by DNA methylation in tumorigenesis
Jingmin Shu et al.
CANCER RESEARCH (2006)
Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer
T Fukui et al.
ONCOGENE (2005)
Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation
RA Winn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis
C Garnis et al.
HUMAN MOLECULAR GENETICS (2005)
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells
L You et al.
ONCOGENE (2004)
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells
B He et al.
NEOPLASIA (2004)
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
M Lepourcelet et al.
CANCER CELL (2004)
Aberrant nuclear localization and gene mutation of β-catenin in low-grade adenocarcinoma of fetal lung type:: Up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules
Y Nakatani et al.
MODERN PATHOLOGY (2002)
Increased expression of β-catenin predicts better prognosis in nonsmall cell lung carcinomas
F Hommura et al.
CANCER (2002)
Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas
M Ueda et al.
BRITISH JOURNAL OF CANCER (2001)
Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription
SQ Chen et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
